Skip to content
Canadian orders above $200 ship free · Dispatched from Canadian stock

Buy 5-Amino-1MQ in Canada

5-Amino-1MQ in Canada

5-Amino-1MQ as lyophilised powder, offered in 50 mg vials. Every batch is HPLC tested and dispatched from Canadian stock. For laboratory research use only.

Format
Size
$62.00$1.24/mg
Dispatched from Canadian stock

Buy more, pay less per vial

Add 2 more to save 4%

Frequently bought together

At a glance
Also known as
5-amino-1-methylquinolinium · 5A1MQ · 5-AMQ · 5MQ · NNMT inhibitor
Class
Small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor
Form
Lyophilised powder, as 50 mg vials
Sizes
50 mg
Storage, dry
−20 °C, dry and dark
Storage, mixed
2–8 °C, use within 28 days of mixing (as generally reported for reconstituted peptides)
BAC water per size
50 mg: 5 mL

What is 5-Amino-1MQ?

In the literature 5-Amino-1MQ is characterised as a small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor. The work published on it is in rat, mouse and cell culture. Several names across the literature all denote the same material, among them 5-amino-1-methylquinolinium, 5A1MQ and 5-AMQ. Its sequence is recorded as Not a peptide: a quinolinium small molecule, detected in LC-MS/MS at m/z 159.1 (Awosemo et al. 2021). There is no published human study of 5-Amino-1MQ, so nothing on this page describes what it does in a person. Borealis Peptides provides it as lyophilised powder in 50 mg vials for in-vitro laboratory research. None of this is a medicine; it is not for human or veterinary use.

What the research shows

StudyModelDose usedDurationFinding
Babula JJ et al.2024 · Diabetes Obes Metab · PMID 39161060Mouse, diet-induced obese (DIO) mice; plus pharmacokinetics in age- and strain-matched miceNot stated in the abstract (once daily); PK after intravenous, oral and subcutaneous dosing28 days5A1MQ dose-dependently limited body weight and fat mass gains, improved oral glucose tolerance and insulin sensitivity, and reduced hepatic steatosis and liver triglycerides. ALT, AST and ketone bodies were normalised, and subcutaneous dosing distributed it to adipose, muscle and liver.
Neelakantan H et al.2018 · Biochem Pharmacol · PMID 29155147Cell culture (adipocytes, Caco-2 permeability) and mouse, diet-induced obese mice; methylquinolinium NNMT inhibitor series (the abstract does not name the compound used in mice)Not stated in the abstractNot stated in the abstractThe inhibitors reduced 1-MNA, raised NAD+ and SAM and suppressed lipogenesis in adipocytes. In obese mice, a potent inhibitor reduced body weight, white fat mass, adipocyte size and plasma cholesterol without changing food intake or producing observable adverse effects.
Neelakantan H et al.2019 · Biochem Pharmacol · PMID 30753815Mouse, 24-month-old mice with barium chloride tibialis anterior injury, plus C2C12 myoblasts; NNMT inhibitor from the same group (the abstract does not name the compound)5 or 10 mg/kg NNMTi, or saline control1 week or 3 weeks after injuryMuscle stem cell proliferation and fusion increased, myofiber cross-sectional area was nearly 2-fold greater and peak torque of the injured muscle was about 70% higher than in controls.
Dimet-Wiley A et al.2022 · Sci Rep · PMID 35013352Mouse, diet-induced obese mice switched to a low-fat dietNot stated in the abstract (5-amino-1-methylquinolinium with low-fat diet)Not stated in the abstractMice given 5-amino-1MQ plus the low-fat diet had a distinct caecal microbiome, with less Erysipelatoclostridium and more Lactobacillus than vehicle-treated mice on the same diet. The abstract notes the combination normalised adiposity and weight to those of lean mice.
Yang M et al.2024 · J Immunother Cancer · PMID 39067875Mouse, urothelial bladder cancer models; plus human bladder cancer tissue cohorts (association data)Not stated in the abstract (5-amino-1-methylquinolinium iodide)Not stated in the abstractTargeting NNMT with 5-amino-1-methylquinolinium iodide reduced tumour growth and enhanced the apoptotic effects of an anti-PD-L1 antibody in mouse models. The human data were associations between NNMT in tumour fibroblasts and non-response to immunotherapy.
Awosemo O et al.2021 · J Pharm Biomed Anal · PMID 34304009Rat, pharmacokinetic study with a validated LC-MS/MS assayNot stated in the abstract (intravenous and oral)Not stated in the abstract5-AMQ reached substantial plasma exposure by both routes, with a mean maximum plasma concentration of 2252 ng/mL after oral dosing. The first terminal half-life reported was 3.80 ± 1.10 h; the stored abstract is cut off before the second value.
Akar S et al.2021 · J Obstet Gynaecol · PMID 33645410Cell culture (HeLa cervical cancer cells, HEK-293 cells)0.1–500 µM 5MQ (5-amino-1-methylquinolinium)Not stated in the abstract5MQ inhibited HeLa cell proliferation in a concentration- and time-dependent manner, with signs of apoptosis and lower phospho-Akt and SIRT1 protein. HEK-293 cell proliferation was not apparently affected.

What these studies don't show: This work was carried out in animals and cells. The question of human effect stays open, since no human study exists. The dose, route and timing used in an animal model do not carry over to people, and nothing here should be read as though they did. A certificate of analysis answers what the material is, not what it does.

Every study links to its PubMed record. See all 5-Amino-1MQ studies in the research library →

5-Amino-1MQ price in Canada: 50mg vial

Buy 5-Amino-1MQ in Canada in a 50mg vial and a starter kit. Prices are in Canadian dollars, you pay by Interac e-Transfer or bank transfer, and orders are shipped from Canadian stock.

SizePricePer mg
50 mg$62.00$1.24/mg

Starter kit

Is 5-Amino-1MQ available in Canada?

5-Amino-1MQ carries no Drug Identification Number, which is the mark Health Canada gives a drug it has authorized. Health Canada has conducted no safety, efficacy or quality review of it. Borealis Peptides provides it strictly for in-vitro laboratory research, never for human or veterinary use. How Health Canada treats research peptides →

Side effects reported in studies

The studies cited below set out their own tolerability observations, and those statements appear here exactly as written. Animal and cell work on this scale does not pin down a safety profile. Read more →

Doses used in studies

Read more →

5-Amino-1MQ FAQ

What is 5-Amino-1MQ?

Chemically, 5-Amino-1MQ falls into the class of small-molecule nicotinamide N-methyltransferase (NNMT) inhibitors. Its published work is in rat, mouse and cell culture. Borealis Peptides provides it as lyophilised powder in 50 mg vials for in-vitro laboratory research. None of this is a medicine; it is not for human or veterinary use. Every reference here appears with the model it ran in and the finding as published.

Where can I buy 5-Amino-1MQ in Canada?

Straight from Borealis Peptides, kept in Canadian stock so nothing crosses a border to reach you. Available in 50 mg vials. Purity is verified by HPLC one batch at a time, and we supply for laboratory research only. HPLC is run on each batch, and the certificate you receive is for the batch you were sent.

Is 5-Amino-1MQ legal in Canada?

5-Amino-1MQ carries no Drug Identification Number, which is the mark Health Canada gives a drug it has authorized. Health Canada has conducted no safety, efficacy or quality review of it. Borealis Peptides provides it strictly for in-vitro laboratory research, never for human or veterinary use. Because Health Canada has stated that "Research Use Only" labelling does not make a product legal to use in a person, we take it to set out what the material is supplied for, not a licence to use it.

How much 5-Amino-1MQ should I use?

There is none to give. Nothing on this site amounts to a protocol, a schedule or a reconstitution volume. The amounts in the cited studies belong to those studies and the models they ran in, and they are listed so the evidence can be weighed rather than accepted on trust.

Has 5-Amino-1MQ been tested in people?

No. The 7 studies cited here used animals or cell culture. No published human study of 5-Amino-1MQ exists, so there is no evidence about what it does in a person, and this page makes no claim about that. The animal work is listed with its model so it can be read for what it is.

What storage does 5-Amino-1MQ need?

While unopened, keep it at −20 °C in the dark. Once reconstituted, store at 2–8 °C. Room-temperature transit does the dry powder no harm, and it should be refrigerated once received. Keeping it dark and at an even temperature counts for more than how quickly it reached you.

How is the purity of 5-Amino-1MQ confirmed?

Identity and purity are verified by HPLC for every batch rather than once per product. The certificate states which batch it covers, and that batch number is printed on the vial, so any result can be traced back to the exact material behind it. Send us your order number and we forward it.

How does 5-Amino-1MQ compare with NAD+ and MOTS-C?

They are not interchangeable, and this page makes no claim that one is preferable. NAD+ and MOTS-C have 8 cited studies and 7 cited studies on their page against 7 here. The comparison that helps is between the two study tables and the models behind them.

Compare with